Candel Therapeutics Inc. (NASDAQ: CADL) Stock Information | RedChip

Candel Therapeutics Inc. (NASDAQ: CADL)


$8.2700
-0.4800 ( -3.28% ) 977.6K

Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Market Data


Open


$8.2700

Previous close


$8.7500

Volume


977.6K

Market cap


$355.34M

Day range


$7.9160 - $9.1590

52 week range


$1.1000 - $14.6000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jul 15, 2024
8-k 8K-related 11 Jun 28, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024

Latest News